InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Announcements

Current share price for AVR : $9.590 0.04 (0.42%)+

ASX company news and announcements for Anteris Technologies Ltd (AVR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anteris Technologies Ltd (AVR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anteris Technologies Ltd (AVR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anteris Technologies Ltd (AVR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$139 Proposed issue of securities - AVR 24 Jul 2024 9:45AM $17.050 $9.590 fallen by 43.75%
$139 Capital Raise 24 Jul 2024 9:45AM $17.050 $9.590 fallen by 43.75%
$139 Trading Halt 22 Jul 2024 9:58AM $17.050 $9.590 fallen by 43.75%
$139 Pause in trading 22 Jul 2024 9:49AM $17.050 $9.590 fallen by 43.75%
$139 Anteris and v2vmedtech Announce Concept Lock for VClip 1 Jul 2024 9:38AM $18.310 $9.590 fallen by 47.62%
$139 Change of Director's Interest Notice 25 Jun 2024 5:38PM $18.400 $9.590 fallen by 47.88%
$139 Notification regarding unquoted securities - AVR 25 Jun 2024 5:34PM $18.400 $9.590 fallen by 47.88%
$139 FIH Data Confirms Optimal Valve Positioning with ComASUR 20 Jun 2024 9:28AM $19.000 $9.590 fallen by 49.53%
$139 Update on Pivotal Trial Submission 18 Jun 2024 9:53AM $18.750 $9.590 fallen by 48.85%
$139 Update on DurAVR Valve-in-Valve Experience 13 Jun 2024 9:48AM $19.300 $9.590 fallen by 50.31%
$139 Data Update on First-in-Human Study of DurAVR at NY Valves 11 Jun 2024 1:10PM $18.770 $9.590 fallen by 48.91%
$139 Notification of cessation of securities - AVR 31 May 2024 8:28AM $18.750 $9.590 fallen by 48.85%
$139 Results of Annual General Meeting 29 May 2024 2:56PM $18.950 $9.590 fallen by 49.39%
$139 AGM Chairman and CEO Presentation 29 May 2024 9:59AM $19.200 $9.590 fallen by 50.05%
$139 Notice of Annual General Meeting - Withdrawal of Resolution 28 May 2024 5:59PM $19.200 $9.590 fallen by 50.05%
$139 First in Human TAVR in TAVR in SAVR using DurAVR 15 May 2024 9:55AM $20.500 $9.590 fallen by 53.22%
$139 Cleansing Notice 13 May 2024 3:03PM $20.500 $9.590 fallen by 53.22%
$139 Application for quotation of securities - AVR 13 May 2024 11:30AM $20.750 $9.590 fallen by 53.78%
$139 Notification regarding unquoted securities - AVR 2 May 2024 2:16PM $21.210 $9.590 fallen by 54.79%
$139 Notice of Annual General Meeting/Proxy Form 29 Apr 2024 2:24PM $22.250 $9.590 fallen by 56.90%
$139 Cleansing Notice 18 Apr 2024 12:05PM $23.180 $9.590 fallen by 58.63%
$139 Quarterly Activities/Appendix 4C Cash Flow Report 18 Apr 2024 11:54AM $23.180 $9.590 fallen by 58.63%
$139 Application for quotation of securities - AVR 17 Apr 2024 11:16AM $22.900 $9.590 fallen by 58.12%
$139 Application for quotation of securities - AVR 15 Apr 2024 5:58PM $23.000 $9.590 fallen by 58.30%
$139 Corporate Governance Statement and Appendix 4G 15 Apr 2024 10:19AM $23.200 $9.590 fallen by 58.66%

251 - 275 of 718 results

Page 11 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.